The Food and Drug Administration (FDA) has accepted for filing the supplemental Biologics License Application (sBLA) for omalizumab (Genentech) for the treatment of adults with chronic rhinosinusitis ...
The US Food and Drug Administration (FDA) is set to review GlaxoSmithKline’s (GSK) Nucala, after accepting a regulatory submission seeking approval for its use in patients with chronic rhinosinusitis ...
A search of the peer-reviewed literature turned up inconsistent findings on the effectiveness of corticosteroid irrigation for the treatment of chronic rhinosinusitis (CRS) with nasal polyps. The ...
Sanofi and Regeneron’s Dupixent has had the US market for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) mainly to itself since June 2019, but GlaxoSmithKline’s Nucala is now ...
GSK (NYSE:GSK) announced Tuesday that the EU drug regulator has agreed to review depemokimab, an experimental monoclonal antibody targeting a class of cell signaling molecules called interleukin-5, ...
Nasal polyps are common, noncancerous, teardrop-shaped growths that form in your nose or sinuses. They’re usually found around the area where the sinuses open into the nasal cavity. Mature ones look ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Laurimed LLC today announced that the company’s PolypVac ® Microdebrider for removing nasal polyps has appeared on the popular television program “The Doctors”, ...
A simple and convenient option for nasal polyp removal in-office debuted on the CBS TV show "The Doctors" early this year and is now being used to perform sinus procedures at Ear, Nose and Throat ...
Nasal polyps are noncancerous growths in the nasal passages that can result from prolonged irritation due to infections, allergies, or other triggers like asthma. Symptoms of nasal polyps include a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback